TRANSPLANTATION PROCEEDINGS, cilt.48, sa.6, ss.2162-2167, 2016 (SCI-Expanded)
Background. Continuous-flow left ventricular assist devices (CF-LVADs) such as the HeartMate II and HeartWare left ventricular assist device are important alternatives to heart transplantation. Thrombosis is a serious complication in both devices and we present our approach to treating thrombosis and analysis of predisposition factors.